Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting ROCK2 improves macromolecular permeability in a 3D fibrotic pancreatic cancer microenvironment model. | J Control Release | 2024 | 38522816 | PubTator, text mining | PubMed |
| CircZCCHC2 (hsa_circ_0000854) promotes hepatocellular carcinoma progression through modulating miR-936/BTBD7 axis and activating Rho/ROCK2 pathway. | Noncoding RNA Res | 2024 | 38511064 | PubTator, text mining | PubMed |
| Nigella sativa, Anthemis hyaline and Citrus sinensis extracts reduce SARS-CoV-2 replication by fluctuating Rho GTPase, PI3K-AKT, and MAPK/ERK pathways in HeLa-CEACAM1a cells. | Gene | 2024 | 38485035 | PubTator, text mining | PubMed |
| Activation of RhoA/ROCK2 signaling by hypoxia-inducible factor 1α in promoting tumor growth and metastasis in human colon cancer. | J Gastrointest Oncol | 2024 | 38482232 | PubTator, text mining | PubMed |
Two-Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared With Oral Tablet Reference in Healthy Male Participants. | Clin Pharmacol Drug Dev | 2024 | 38345529 | PubTator, text mining | PubMed |
| Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology. | Aging (Albany NY) | 2024 | 38329441 | PubTator, text mining | PubMed |
| Circ_0114428 knockdown inhibits ROCK2 expression to assuage lipopolysaccharide-induced human pulmonary alveolar epithelial cell injury through miR-574-5p. | J Physiol Sci | 2024 | 38297223 | PubTator, text mining | PubMed |
| Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma. | J Bone Oncol | 2024 | 38288377 | PubTator, text mining | PubMed |
| Developmental morphogens direct human induced pluripotent stem cells toward an annulus fibrosus-like cell phenotype. | JOR Spine | 2024 | 38283179 | PubTator, text mining | PubMed |
| Discovery of a novel ROCK2 ATP competitive inhibitor by DNA-encoded library selection. | Biochem Biophys Res Commun | 2024 | 38280309 | PubTator, text mining | PubMed |
| Marine Streptomyces-Derived Novel Alkaloids Discovered in the Past Decade. | Mar Drugs | 2024 | 38276653 | PubTator, text mining | PubMed |
| Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases. | Genes (Basel) | 2024 | 38275604 | PubTator, text mining | PubMed |
| The Role of Rho Kinase Inhibitors in Corneal Diseases. | Drug Des Devel Ther | 2024 | 38264539 | PubTator, text mining | PubMed |
| Regulation of Angiogenesis by Non-Coding RNAs in Cancer. | Biomolecules | 2024 | 38254660 | PubTator, text mining | PubMed |
| Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review. | Noncoding RNA | 2024 | 38250807 | PubTator, text mining | PubMed |
| G-protein signaling of oxytocin receptor as a potential target for cabazitaxel-resistant prostate cancer. | PNAS Nexus | 2024 | 38250514 | PubTator, text mining | PubMed |
| Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis. | J Clin Transl Hepatol | 2024 | 38250467 | PubTator, text mining | PubMed |
| Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy. | J Transl Med | 2024 | 38246995 | PubTator, text mining | PubMed |
| Potential role of RhoA GTPase regulation in type interferon signaling in systemic lupus erythematosus. | Arthritis Res Ther | 2024 | 38243295 | PubTator, text mining | PubMed |
| Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance. | Mol Cancer | 2024 | 38243280 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=13